Contract awardedRapid diagnostic and community diagnostic pathway services

Westcliffe Health Innovations provides diagnostics at Bradford's CDC

Bradford Teaching Hospitals NHS Foundation Trust awarded Westcliffe Health Innovations a contract for community diagnostic centre services at Eccleshill Treatment Centre.

The Bradford CDC was built around a single-site diagnostic model. It brings NHS and independent sector services together in one place, so patients reach diagnostics more easily and the service runs more efficiently. Westcliffe works inside clinical pathways shared with the trust and alongside the trust's own services.

The trust awarded the £19.5m contract directly in April 2026, without a competition. It runs for an initial 12 months, and extensions could take it to March 2029.

What
Rapid diagnostic and community diagnostic pathway services
Value
£19.5m
How it was bought
Award procedure without prior publication of a call for competition
1 bid
Dates and next
13 Apr 2026

How it was bought

1 official notice
  1. 22 Apr 2026Award noticeFind a Tender

How it compares

With every rapid diagnostic and community diagnostic pathway services award since 2021

Half of awards fall between £990,138 and £32.2mMedian £6.12m

Awards
24
Firms that won them
75
Median award
£6.12m
of 21 with a value
This award
Bigger than 62%
of them
Typical length
1.5 years
In Yorkshire and the Humber
5 awards

Westcliffe Health Innovations ranks 9th of 75 firms for rapid diagnostic and community diagnostic pathway services awards since 2021.

RankFirmAwardsValue
1Locked6£190.9m
2Locked3£38.7m
2Locked3£25m
4Locked2£82.7m
4Locked2£32.2m
4Locked2£404,620
9Westcliffe Health Innovations Won this one1£19.5m
See who wins this work

Figures to 21 November 2026

Rapid diagnostic and community diagnostic pathway services at other buyers

Bradford Teaching Hospitals NHS Foundation Trust has awarded 526 contracts since 2021.

See Bradford Teaching Hospitals NHS Foundation Trust's page
  • Westcliffe Health Innovations has won 11 public contracts since 2021.